• Ceftolozane Sulfate: Assay Design for Resistance Biology

  2026-09-25

  Ceftolozane sulfate research is most informative when susceptibility results are interpreted alongside resistance mechanisms and drug exposure. This guide connects target biology, assay design, and translational models while distinguishing ceftolozane activity from that of the ceftolozane–tazobactam combination.

• Imipenem Workflows for Antibacterial Research

  2026-09-25

  Imipenem supports more than susceptibility testing: its PBP-directed antibacterial activity and reported effects on phagocytosis make it useful for paired pathogen–host assays. This workflow guide connects bench screening to emerging localized-delivery research while distinguishing established findings from exploratory applications.

• MTT Assay: Workflow, Applications & Troubleshooting

  2026-09-24

  Use MTT to compare metabolic activity across treatment groups, including bone marrow stromal cell studies, while keeping in mind that signal is not a direct cell count. This practical guide covers an adaptable workflow, controls, optimization, and the interpretation lessons from research on neohesperidin and steroid-induced osteonecrosis.

• VX-765 and the Logic of Cell-Death Assays

  2026-09-24

  VX-765 helps researchers test whether inflammatory cytokine release and macrophage pyroptosis depend on caspase-1. This article connects that focused use to new evidence that RNA polymerase II loss can trigger a distinct apoptotic response, offering a practical framework for interpreting cell-death assays without conflating mechanisms.

• Dacomitinib Workflows for Pan-HER Cancer Research

  2026-09-23

  Use Dacomitinib (PF-00299804) to interrogate ErbB signaling, durable target inhibition, and cancer-cell responses in receptor-dependent models. This workflow pairs practical dose and washout designs with a carefully bounded way to explore mitochondrial ferroptosis biology—without assuming the pathways are already linked.

• Moxidectin Boosts Polyenes Against Oral Candidiasis

  2026-09-23

  The 2024 reference study identifies moxidectin as a potentiator that increases Candida albicans ergosterol levels, thereby strengthening the activity of amphotericin B and Nystatin against fungal growth and biofilms. Transcriptomic, mutant, binding, and mouse infection experiments connect this target-amplification mechanism to reduced oral candidiasis, while also defining important limits for clinical translation.

• Aztreonam Workflows for Gram-Negative Research

  2026-09-22

  Aztreonam supports controlled studies of Gram-negative bacterial inhibition, resistance phenotyping, and translational toxicity signals. This practical guide connects assay setup, plasmid-focused epidemiology, cell-based testing, and troubleshooting around one research-ready monocyclic β-lactam antibiotic.

• MK-4827 and BRCA2: Reframing PARP Sensitivity

  2026-09-22

  MK-4827 (Niraparib) provides a precise tool for studying PARP-dependent DNA damage repair inhibition. This article explains how hyperthermia-induced BRCA2 loss can create a reversible, functional homologous-recombination defect and reshape assay design beyond mutation-based models.

• Sunitinib Workflows for RTK and Angiogenesis

  2026-09-21

  Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor for dissecting VEGFR and PDGFR signaling, tumor angiogenesis, and cancer-cell responses. This guide converts its formulation profile and a recent phosphoproteomic study into practical workflows for dose-response, target engagement, apoptosis, cell-cycle, and resistance experiments.

• Spirocyclic POM Analogues as MmpL3 Inhibitors

  2026-09-20

  This 2024 Bioorganic Chemistry study develops spirocyclic phenyl oxazole methyl analogues as a new chemical series against Mycobacterium tuberculosis. The lead compound 5c combined submicromolar activity with activity against drug-resistant clinical isolates, favorable early pharmacology, low THP-1 cytotoxicity, and genetic evidence implicating the essential transporter MmpL3.

• Ceftazidime B3539 for Reliable Assays

  2026-09-19

  Learn how Ceftazidime SKU B3539 can support controlled antimicrobial and infection-model workflows without obscuring mammalian cell viability readouts. This scenario-based guide covers solvent compatibility, stock handling, susceptibility testing, resistance interpretation, and practical product selection.

• Cardiogreen: Reliable Cell Assay Workflows

  2026-09-18

  Learn how Cardiogreen (Indocyanine Green), SKU B8315, can support controlled viability, proliferation, cytotoxicity, and photodynamic therapy workflows. This scenario-based guide covers optical interference, treatment controls, solution handling, mechanistic interpretation, and practical vendor selection.

• BAP1, SLC7A11, and Disulfidptosis in Cancer

  2026-09-18

  The reference study identifies BAP1 as a suppressor of disulfidptosis, linking its transcriptional control of SLC7A11 to cystine flux and cellular NADPH availability. Its findings show how the same BAP1–SLC7A11 axis can oppose disulfidptosis while promoting ferroptosis, emphasizing the importance of metabolic context when interpreting tumor suppressor function.

• Mouse Neutrophil Cell Isolation Kit: Assay Logic

  2026-09-17

  The Mouse Neutrophil Cell Isolation Kit supports rapid, high-purity enrichment while minimizing direct labeling of target cells. This article explains how tissue origin, selection chemistry, and assay design affect interpretation in neutrophil-targeted immunotherapy research.

• Meropenem trihydrate in Resistance Workflows

  2026-09-17

  Use Meropenem trihydrate as a controlled antibacterial perturbation for MIC testing, resistance phenotyping, and metabolomics-informed assay design. This workflow connects rapid LC-MS/MS signatures with practical experiments in gram-negative bacterial infections and translational infection models.

7976 records 1/532 page Next 12345 下5页 Last page